EUVIMEDEUVIMED entdecken
Crossref

Investigation of the Potential Anti‐Diabetic Kidney Disease Mechanism of Gynura procumbens (Lour.) Merr via Transcriptomics Combined With Network Pharmacology

Yi Liu iD, Wenbin Ruan, Shuting Zhai, Li Li, Jian'an Sun, Mingzhen He, Juan Cao

Rapid Communications in Mass Spectrometry · 15.07.2026 · 40 (13)

DOI: 10.1002/rcm.70065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 12.04.2026. Verfasst von Yi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Asteraceae, Plant Extracts, Diabetic Nephropathies, Transcriptome. Die Arbeit nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Standards Committee of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Effective treatments for diabetic kidney disease are currently lacking. This study aimed to investigate the therapeutic mechanism of Gynura procumbens (Lour.) Merr against diabetic kidney disease.

Methods

The 70% ethanol extract of Gynura procumbens (Lour.) Merr was analyzed by UPLC‐Q/TOF‐MS/MS. A diabetic kidney disease mouse model was established to evaluate its efficacy. Mechanisms were predicted via network pharmacology and validated through transcriptomic, protein, and gene expression analyses.

Results

A total of 32 compounds and 13 active ingredients were identified in Gynura procumbens (Lour.) Merr. Network pharmacology predicted that these active ingredients regulate multiple targets (such as interleukin‐6, RELA proto‐oncogene, nuclear factor erythroid 2‐related factor 2, peroxisome proliferator‐activated receptor alpha, etc.). Transcriptomics not only verified the activation of inflammatory pathways but also revealed regulation of lipid metabolism. We found that intervention with Gynura procumbens (Lour.) Merr can modulate the peroxisome proliferator‐activated receptor alpha pathway, inhibit nuclear factor kappa‐B, and increase the expression of antioxidant markers (nuclear factor erythroid 2‐related factor 2 and Heme oxygenase 1).

Conclusion

This study employs an integrated transcriptomic and network pharmacology approach to investigate the anti‐diabetic kidney disease mechanism of Gynura procumbens (Lour.) Merr, offering a foundation for further pharmacological validation and drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsteraceaePlant ExtractsDiabetic NephropathiesTranscriptomeAnimalsMiceNetwork PharmacologyTandem Mass SpectrometryMaleGene Expression ProfilingPPAR alpha

Stichwörter der Autor:innen

Gynura procumbens (Lour.) MerrUPLC‐Q/TOF‐MS/MSdiabetic kidney diseasenetwork pharmacologytranscriptomics

Substanzen

Plant ExtractsPPAR alpha

Autor:innen und Institutionen

  • Jiangxi University of Chinese Medicine, Nanchang, China.
  • Jiangxi Provincial Children's Hospital, Nanchang, China.

ORCID-Profile: Yi Liu

Förderung

  • National Natural Science Foundation of China
  • Jiangxi Provincial Standards Committee of Traditional Chinese Medicine

Zitieren

APA

Liu, Y., Ruan, W., Zhai, S., Li, L., Sun, J., He, M., & Cao, J. (2026). Investigation of the Potential Anti‐Diabetic Kidney Disease Mechanism of Gynura procumbens (Lour.) Merr via Transcriptomics Combined With Network Pharmacology. Rapid Communications in Mass Spectrometry, 40(13). https://doi.org/10.1002/rcm.70065

Vancouver

Liu Y, Ruan W, Zhai S, Li L, Sun J, He M, et al. Investigation of the Potential Anti‐Diabetic Kidney Disease Mechanism of Gynura procumbens (Lour.) Merr via Transcriptomics Combined With Network Pharmacology. Rapid Communications in Mass Spectrometry. 2026;40(13). doi:10.1002/rcm.70065

BibTeX
@article{Liu2026,
  author = {Liu, Yi and Ruan, Wenbin and Zhai, Shuting and Li, Li and Sun, Jian'an and He, Mingzhen and Cao, Juan},
  title = {Investigation of the Potential Anti‐Diabetic Kidney Disease Mechanism of Gynura procumbens (Lour.) Merr via Transcriptomics Combined With Network Pharmacology},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2026},
  volume = {40},
  number = {13},
  doi = {10.1002/rcm.70065}
}
Kostenlos starten →